D
David O. Beenhouwer
Researcher at University of California, Los Angeles
Publications - 47
Citations - 2578
David O. Beenhouwer is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Veterans Affairs & Cryptococcus neoformans. The author has an hindex of 16, co-authored 43 publications receiving 2321 citations. Previous affiliations of David O. Beenhouwer include University of California, Berkeley & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
COVID-19-Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study.
Cristina V. Cardemil,Cristina V. Cardemil,Rebecca M. Dahl,Mila M. Prill,Jordan Cates,Sheldon T. Brown,Sheldon T. Brown,Adrienne Perea,Vincent C. Marconi,Vincent C. Marconi,LaSara Bell,Maria C. Rodriguez-Barradas,Gilberto Rivera-Dominguez,David O. Beenhouwer,Aleksandra Poteshkina,Mark Holodniy,Mark Holodniy,Mark Holodniy,Cynthia Lucero-Obusan,Cynthia Lucero-Obusan,Neha Balachandran,Aron J. Hall,Lindsay Kim,Lindsay Kim,Gayle E Langley +24 more
TL;DR: COVID-19 surveillance at the 5 Veterans Affairs Medical Centers across the United States demonstrated higher hospitalization rates and severe outcomes among older veterans, as well as higherospitalization rates among Hispanic or Latino and non-Hispanic Black veterans than among non- Hispanic White veterans.
Proceedings ArticleDOI
Bacterial biofilm disruption using laser generated shockwaves
Zachary Taylor,Artemio Navarro,Colin Kealey,David O. Beenhouwer,David A. Haake,Warren S. Grundfest,Vijay Gupta +6 more
TL;DR: A system was built to test the efficacy of bacterial biofilm disruption using laser generated shockwaves and results show a 55% reduction in the number living bacteria between shocked and control samples, which could prove useful in the treatment of infected wounds.
Journal Article
Outpatient parenteral antimicrobial therapy at large Veterans Administration medical center.
Andrew Lai,PharmD Thuong Tran,Hien M. Nguyen,Jacob Fleischmann,David O. Beenhouwer,Mph and Christopher J. Graber +5 more
TL;DR: Despite patients' high level of comorbidity and the authors' facility's large catchment area, the outpatient parenteral antimicrobial therapy program was able to deliver OPAT successfully and safely with significant cost savings.
Journal Article
Mechanisms of action of tumor necrosis factor antagonist and granulomatous infections.
Journal ArticleDOI
Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxins.
Machi Yanai,Miguel A. Rocha,Anthony Z. Matolek,Archana Chintalacharuvu,Yasuhiko Taira,Koteswara R. Chintalacharuvu,David O. Beenhouwer +6 more
TL;DR: The results showed that LukGH was more cytotoxic to human PMNs than PVL, however, LukGH-induced calcium ion influx in PMNs was markedly attenuated and slower than that induced by PVL and other staphylococcal BCLs.